Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Nuclear Medicine

• Publication date

  1988-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 3193206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration.

  1987cited by this paper
• Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.

  1986cited by this paper
• Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms.

  1986cited by this paper
• Monoclonal antibody imaging and therapy of solid tumors

  1986cited by this paper
• Antibody-guided irradiation of malignant pleural and pericardial effusions.

  1986cited by this paper
• Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody.

  1986cited by this paper
• 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.

  1986cited by this paper
• Antibody-guided lymphangiography in the staging of cervical cancer.

  1986cited by this paper
• Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.

  1986cited by this paper
• Antibody‐Guided Irradiation of Malignant Ascites in Ovarian Cancer: A New Therapeutic Method Possessing Specificity Against Cancer Cells

  1986cited by this paper
• Illusions of tumour killing using radiolabelled antibodies.

  1986cited by this paper
• DTPA-coupled antibodies labeled with yttrium-90.

  1985cited by this paper
• Antibody guided lymphangiography in the staging of cervical cancer.

  1985cited by this paper
• Radioimmunodetection in patients with suspected ovarian cancer.

  1985cited by this paper
• Theoretical and experimental bases of intraperitoneal chemotherapy.

  1985cited by this paper
• Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.

  1985cited by this paper
• Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease.

  1985cited by this paper
• Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix.

  1985cited by this paper
• Theoretical and experimental bases of intraperitoneal chemotherapy.

  1985cited by this paper
• Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast‐associated determinants

  1984cited by this paper
• Immunoscintigraphy of colon carcinoma.

  1984cited by this paper
• Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

  1984cited by this paper
• Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies.

  1984cited by this paper
• Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells.

  1983cited by this paper
• Radioactive labeling of antibody: a simple and efficient method.

  1983cited by this paper
• Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.

  1982cited by this paper
• Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers

  1981cited by this paper
• Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

  1981cited by this paper
• Multilocus enzyme systems and the evolution of gene expression: the alkaline phosphatases as a model example.

  1980cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper

• Locoregional Radionuclide Therapy of Primary and Metastatic Cancers

  2012cites this paper
• Intraperitoneally administered wY-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions

  2007cites this paper
• Preclinical Analysis of Intraperitoneal Administration of 1111 n-labeledHuman Tumor Reactive Monoclonal 1 gM AC 6 C 3-2 B 12 '

  2006cites this paper
• An IgMA human tumor cell-reactive monoclonal antibody was devel o_ that reacts with cells of ovarian cancer, colorectal cancer, breast cancer, and certain other malignancies. The monoclonal antibody AC6C3-

  2006cites this paper
• Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice

  2005cites this paper
• Intraperitoneal Radioimmunotherapy of Ovarian Cancer: Radiobiological Basis, Clinical Status and Future Prospects

  2000cites this paper
• Radioimmunodiagnosis and therapy.

  2000cites this paper
• Targeting Peptides for Pleural Cavity Tumor Radiotherapy: Specificity and Dosimetry of Re-188-RC-160

  1997cites this paper
• Pre-clinical experience with Re-188-RC-160, a radiolabeled somatostatin analog for use in peptide-targeted radiotherapy.

  1997cites this paper
• Development of prodrugs for ADEPT (antibody-directed enzyme prodrug therapy)

  1996cites this paper
• Section Review: Biologicals & Immunologicals: Development of prodrugs for ADEPT (antibody-directed enzyme prodrug therapy)

  1996cites this paper
• Radioimmunoscintigraphy of Ovarian Tumours with Tc-99m Labelled Monoclonal Antibody-170

  1995cites this paper
• Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences

  1995cites this paper
• Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.

  1995cites this paper
• Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer.

  1995cites this paper
• Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs.

  1995cites this paper
• Problems of Delivery of Monoclonal Antibodies

  1995cites this paper
• Recent developments in radioimmunotherapy.

  1994cites this paper
• Antibody-targeted drugs for the therapy of cancer.

  1994cites this paper
• Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment

  1994cites this paper
• Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6.

  1994cites this paper
• Dosimetry of intraperitoneally administered radiolabeled antibodies.

  1993cites this paper
• Radioimmunodetection of ovarian cancer.

  1993cites this paper
• Radioimmunotherapy with 90Y-labeled monoclonal antibodies in a nude mouse ovarian cancer model.

  1993cites this paper
• Monoclonal antibodies in the management of ovarian cancer: A clinical perspective

  1993cites this paper
• Targeted Immunotherapy: An Update with Special Emphasis on Ovarian Cancer

  1993cites this paper
• Radioimmunotherapy of Ovarian Cancer

  1993cites this paper
• Radioimmunotherapy: clinical results and dosimetric considerations.

  1992cites this paper
• The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).

  1992cites this paper
• RADIOIMMUNOTHERAPY STUDIES IN BREAST CANCER

  1992cites this paper
• Immunotherapy of breast cancer.

  1992cites this paper
• Clinical evaluation of radioimmunoimaging with 131I-C0C183B2 monoclonal antibody against ovarian carcinoma by intraperitoneal injection.

  1992cites this paper
• Imaging of human ovarian tumour xenografts in nude mice using a novel 111In-labelled monoclonal antibody (10B).

  1991cites this paper
• Multi‐parameter flow cytometric quantitation of the expression of the tumor‐associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2

  1991cites this paper
• Radioimmunoscintigraphy of Gynecologic Tumors with 131I-Labeled Anti-Plap Monoclonal Antibodies

  1991cites this paper
• Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody.

  1991cites this paper
• Radioimmunotherapy with I-131 Chimeric L-6 in Advanced Breast Cancer

  1991cites this paper
• Radioimmunotherapy for Breast Cancer: Treatment of a Patient with I-131 L6 Chimeric Monoclonal Antibody

  1991cites this paper
• Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions.

  1990cites this paper
• Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

  1990cites this paper
• Immunotherapy of gynecologic malignancies.

  1990cites this paper
• Gynecologic tumor markers.

  1990cites this paper